GlycoMimetics Inc (GLYC)

0.242 +0.03 (+11.78%) USD  |  NASDAQ  |  Dec 24, 16:00
More

GlycoMimetics Free Cash Flow Per Share (Quarterly)

Free Cash Flow Per Share (Quarterly) Chart

View Free Cash Flow Per Share (Quarterly) for GLYC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Per Share (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Per Share (Quarterly) Range, Past 5 Years

View Free Cash Flow Per Share (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Per Share (Quarterly) Benchmarks

View Free Cash Flow Per Share (Quarterly) Benchmarks
Start Trial
Biomarin Pharmaceutical Inc Upgrade
Arbutus Biopharma Corp Upgrade
Revance Therapeutics Inc Upgrade
FibroGen Inc Upgrade
Cidara Therapeutics Inc Upgrade

Free Cash Flow Per Share (Quarterly) Related Metrics

Cash from Operations (Quarterly) Upgrade
Free Cash Flow Upgrade
Free Cash Flow Yield Upgrade